IMCAS

Surgery

EMED - Safety and effectiveness of Argo Plasma for skin tightening

EMED - Plasma in breast surgery

BIODERMOGENESI - Evolution in the treatment of major burns: recovery of life quality and reduction of the social costs

Objectives: The aim of this study was to evaluate the effectiveness of the treatment with VEMF THERAPY on scar tissue of large burns in terms of: change in the appearance of the scar, change in associated painful symptoms, change of scar retraction and any associated functional deficit impact on the quality of life of the patient in response to the treatment.

Introduction: The development of trauma scars is not only a medical and psychological problem but also a picture with social impact. There are no methods for scars' treatment that have been unanimously approved by the health system. The therapy is entirely at the patient’s expense, along with the difficult management of the often traumatic event. In addition, the scar may be accompanied by disabling outcomes where the scar retraction, with functional limitation and/or painful symptomatology, limits the resumption of work activity. This affects the entire society with a loss of human and economic resources.

Materials / method: Patients with extensive burn scars, associated to the aesthetic medicine clinic, were treated with sessions of VEMF THERAPY (Vacuum Electro-Magnetical Field) on a weekly basis with a total number of 10/12 sessions. The following factors were assessed: appearance of the scar (iconographic documentation), variation of tissues (ultrasound), skin characteristics (hydration state, pH, sebum production etc.), sensitivity, spontaneous or motion-induced pain; quality of life parameters such as pain medication consumption, sleep quality, possible resumption of daily activities and work activity (Dash)

Results: We observed an improvement in the appearance of the scars, with a reduction in the associated painful symptoms, until they disappeared. We also observed a reduction in the use of pain medications until they were discontinued, with improved quality of sleep and consequently resumption of daily activities.

Conclusion: The therapy with electromagnetic field and vacuum is presented as confirmed therapeutic proposal for treatment of scars, with proven effectiveness in the aesthetic and functional improvement of the same, ensuring affordable costs in the face of extensive results in terms of rehabilitation of the patients to resume their usual life.

Declaraciones

¿Ha recibido algún tipo de financiamiento para realizar su investigación sobre esta temática?
No

¿Ha recibido algún pago, honorario u otra compensación por su trabajo acerca de esta investigación?
No

¿Tiene vínculos financieros con alguna entidad que podría llegar a competir estrechamente con los medicamentos, materiales o instrumentos tratados en su investigación?
No

¿Posee o ha solicitado una patente relacionada a los materiales, productos o instrumentos utilizados en su investigación?
No

Este trabajo es presentado gracias al apoyo de: BIODERMOGENESI®

DERMEDEN - Post-Inflammatory hyperpigmentation: How to evaluate the risk?

OBAGI - Treatment options for hyperpigmentation: an update

MERZ AESTHETICS - Neck rejuvenation outcomes with Hyperdilute CaHA

MERZ AESTHETICS - Immunogenicity of botulinum toxin

LOVE COSMEDICAL - The new concept of biomodulation with skin boosters, integrating superficial and deep procedures for a modern and fully approach

BAZ BIOMEDIC - A new paradigm in skin rejuvenation with Needle-Free Jet Injector

BAZ BIOMEDIC - CUREJET (Versatile needle-free jet injector), a game changer for acne scar treatment and facial rejuvenation

CGBIO - Advanced Injection Techniques with Calcium Hydroxyapatite for Total Body Rejuvenation

LABORATORIES HYAMED - Pioneering Advances in Beauty and Technology

PLURYAL - Pluryal densify and combination treatment: Aiming to improve skin quality and enhance patient satisfaction

Objectives: This study evaluates the effectiveness of Pluryal Densify, both alone and with other treatments, in improving skin quality and patient satisfaction. We analyze its impact on skin tone, fine lines, wrinkles, elasticity, and radiance. Additionally, we assess how combining it with other treatments optimizes results.

Introduction: BIANCA CLINIC specializes in aesthetic dermatology and plastic surgery, treating diverse patients. Due to rising demand for skin rejuvenation, the clinic frequently uses collagen boosters and injectables.
Pluryal Densify, a combination of polynucleotides (PN), non-crosslinked hyaluronic acid, and mannitol, improves hydration and skin quality.
This study examines its effectiveness alone and in combination with other treatments.

Materials / method: We reviewed clinical cases of Pluryal Densify, used alone or with other treatments.
・Patients: Had concerns like fine lines, pigmentation, and erythema.
・Treatment: Administered every 2-4 weeks over three sessions.
・Combination Therapy: Some patients received laser or microneedling.
・Evaluation: Assessed through before-and-after images and patient feedback on skin texture, hydration, and tone.

Results: ・Pluryal Densify alone improved skin tone, wrinkles, and radiance, with high patient satisfaction.
・Combination treatments further enhanced pigmentation and erythema reduction.
・Most patients saw long-lasting improvements, and over 75% wanted to continue treatment.
・No serious side effects were reported, confirming its safety.

Conclusion: Pluryal Densify effectively improves skin hydration, elasticity, and quality.
While effective alone, combination treatments enhance patient satisfaction and results.
This study suggests Pluryal Densify is a safe, versatile option for aesthetic practitioners seeking better skin rejuvenation outcomes.

Declaraciones

¿Ha recibido algún tipo de financiamiento para realizar su investigación sobre esta temática?
No

¿Ha recibido algún pago, honorario u otra compensación por su trabajo acerca de esta investigación?
No

¿Tiene vínculos financieros con alguna entidad que podría llegar a competir estrechamente con los medicamentos, materiales o instrumentos tratados en su investigación?
No

¿Posee o ha solicitado una patente relacionada a los materiales, productos o instrumentos utilizados en su investigación?
No

Este trabajo no cuenta con el apoyo de ningún financiamiento directo o indirecto. El autor asume plena responsabilidad sobre el mismo.

PLURYAL - Clinical use of polynucleotide preparations in japanese patients: Case studies from our clinic

Objectives: Our clinic has been using various skin rejuvenation agents to help improve our patients’ skin quality. Recently, we have been using a polynucleotide preparation from Luxembourg, which includes three types of formulations. In particular, we use the formulation with mannitol for its added stability and effectiveness.

Introduction: During the COVID pandemic, we saw an increase in patients with facial redness and inflammatory skin issues due to prolonged mask wearing. Polynucleotide preparations have shown anti-inflammatory effect and help improve skin quality, making them well-suited for these cases. We also use combination device-based treatments to achieve better results.

In this presentation, we will share our best clinical practices for patient selection, applying treatments, and the results we observed in our case studies.

Conclusion: I normally use it on patients who would like to treat redness.
Quick results are seen on younger patients in their 20s.
As I showed in my clinical photos, for older patients in their 40s or above, by adding amino acid can enhance results.

I personally see nice results when combining with device treatment such as RF.
I have done different experiments with cannula and needle and mixing of Densify with lidocaine and sodium carbonate.
I do not see any difference in the results and the mixing of lidocaine and sodium carbonate had the least amount of pain.

Declaraciones

¿Ha recibido algún tipo de financiamiento para realizar su investigación sobre esta temática?
No

¿Ha recibido algún pago, honorario u otra compensación por su trabajo acerca de esta investigación?
Si
Por favor especifique las entidades (individuo, empresa, sociedad): infix company

¿Tiene vínculos financieros con alguna entidad que podría llegar a competir estrechamente con los medicamentos, materiales o instrumentos tratados en su investigación?
No

¿Posee o ha solicitado una patente relacionada a los materiales, productos o instrumentos utilizados en su investigación?
No

Este trabajo no cuenta con el apoyo de ningún financiamiento directo o indirecto. El autor asume plena responsabilidad sobre el mismo.

I'LL GLOBAL - Strategies to enhance ECMV booster delivery by nanoporation

DIBI MILANO - Electroporation’s new era in skin treatment with mesotherapy

DIBI MILANO - The future of aesthetic treatments: Non-invasive microneedling and multipolar RF

MONIKA HEILIGMANN - Revolutionizing Lip Care: The Next Era of Non-Invasive Treatments

CLARIUS - Revolutionizing facial mapping through AI-powered ultrasound

I-TECH INDUSTRIES - Pre and post-surgery with microstimulation technology: from tissue preparation to tissue recovery

SKIN TECH PHARMA - Employing new injectable technique for mid face

Objectives: To evaluate the efficacy and safety of innovative BBDE crosslinked low concentrated HMW HA 7 mg/ml (21 mg in stringe 3 ml) associated to antioxidants protective phosphate buffer containing amino acids for the treatment of skin photoaging (J20 Photoaging of the skin according to International Classification of Diseases WHO 11th Revision) of the mid face area by using dermal injections were the aims of that study. Skin quality as non-medical indication was under clinical evaluation during the study.

Introduction: RRS® HA Long Lasting is composed of high molecular weight cross-linked hyaluronic acid associated with amino acids. The brand new UnHeating cross-linking technology is used in creating highly stabilized hyaluronic acid, resistant to degradation and stress, ensuring optimal rheology. HA is biocompatible, biodegradable, nontoxic, ubiquitous across all species no allergic reactions happen with its use, is the main component of ECM.

Materials / method: Prospective, post-marketing, interventional, comparative before-after, single-arm, non-randomized, open-label clinical investigation of the medical device containing viscoelastic, sterile, apyrogenic, buffered, BBDE-crosslinked sodium hyaluronate (HA) associated to antioxidants protective phosphate buffer with amino acids ( RRS HA LONG LASTING, Skin Tech Pharma Group, Spain ) administered to the patients with skin mid facial photoaging in a single session and a follow-up period of up to 28 days.
A total of 52 subjects were recruited and enrolled in the study.

Results: 29 subjects were found suitable for the study . This intervention involved the secondary investigator administered the product. According to the design study, evaluation of the degree of skin photoaging according to the Alexiades-Armenakas scale, wrinkles severity rate (WSRS), aesthetic improvement analysis GAI demonstrated high efficacy of hydrogel in mid face. At 14 days after the use, a notable average reduction of 11 % was observed in the Alexiades-Armenakas scale when compared to the baseline measurement.

Conclusion: The principal aim of this clinical investigation was to assess the efficacy of the RRS® HA LONG LASTING medical device in ameliorating the hydration levels of skin afflicted by photoaging on the mid face. Specifically, this study targeted subjects exhibiting mild to moderate photoaging, as categorized according to the Alexiades-Armenakas classification system, and individuals with nasolabial folds graded between 2 to 4 on the Wrinkle Severity Rating Scale (WSRS). Evaluation of results confirms high efficacy of one single treatment in mid face area and to low risk of adverse events.

Declaraciones

¿Ha recibido algún tipo de financiamiento para realizar su investigación sobre esta temática?
Si
Por favor especifique las entidades (individuo, empresa, sociedad): individual

¿Ha recibido algún pago, honorario u otra compensación por su trabajo acerca de esta investigación?
Si
Por favor especifique las entidades (individuo, empresa, sociedad): individual

¿Tiene vínculos financieros con alguna entidad que podría llegar a competir estrechamente con los medicamentos, materiales o instrumentos tratados en su investigación?
Si
Por favor especifique las entidades (individuo, empresa, sociedad): individual

¿Posee o ha solicitado una patente relacionada a los materiales, productos o instrumentos utilizados en su investigación?
No

Este trabajo es presentado gracias al apoyo de: SKIN TECH PHARMA GROUP , SPAIN

Horas	Oradores	Título de la presentación	Resumen	Número
10:00		Surgery		145350
10:00	Lukasz WESOLOWSKI	EMED - Safety and effectiveness of Argo Plasma for skin tightening		139038
10:15	Dr Samir IBRAHIM	EMED - Plasma in breast surgery		139083
10:30		Clinical Dermatology		145352
10:30	Dr Sara ZECCHETTO	BIODERMOGENESI - Evolution in the treatment of major burns: recovery of life quality and reduction of the social costs	Ver	139040
10:45	Dr Barbara DALBOS BOUILLARD	DERMEDEN - Post-Inflammatory hyperpigmentation: How to evaluate the risk?		139046
11:00	Dr Barbara DALBOS BOUILLARD	DERMEDEN - Tips and medical advice to avoid post-inflammatory hyperpigmentation		139086
11:15	Dr Suzan OBAGI	OBAGI - Treatment options for hyperpigmentation: an update		139036
11:30	Dr Suzan OBAGI	OBAGI - Treatment options for hyperpigmentation: an update		139037
11:45		Injectables		145357
11:45	Dr Ciara ABBOTT	MERZ AESTHETICS - Neck rejuvenation outcomes with Hyperdilute CaHA		140934
12:00	Dr Simone VOGEL	MERZ AESTHETICS - Immunogenicity of botulinum toxin		140933
12:15	Dr Fiorella DERIU	LOVE COSMEDICAL - The new concept of biomodulation with skin boosters, integrating superficial and deep procedures for a modern and fully approach		139094
12:30	Dr Kyuho YI	HYUNDAE MEDITECH - Skin Boosters : Definitions and varied classifications		139087
12:45	Dr Ahsung KIM	BAZ BIOMEDIC - A new paradigm in skin rejuvenation with Needle-Free Jet Injector		139052
13:00	Dr Shinji NODA	BAZ BIOMEDIC - CUREJET (Versatile needle-free jet injector), a game changer for acne scar treatment and facial rejuvenation		139051
13:15	Dr Renato PAZZINI	CGBIO - Advanced Injection Techniques with Calcium Hydroxyapatite for Total Body Rejuvenation		139043
13:30	Dr Renato PAZZINI	CGBIO - Advanced Injection Techniques with Calcium Hydroxyapatite for Total Body Rejuvenation		139044
13:45	Julien CLEMENT	LABORATORIES HYAMED - Pioneering Advances in Beauty and Technology		139033
14:00	Dr Yuu OKUBO	PLURYAL - Pluryal densify and combination treatment: Aiming to improve skin quality and enhance patient satisfaction	Ver	139102
14:15	Dr Atsuko YANAGAWA	PLURYAL - Clinical use of polynucleotide preparations in japanese patients: Case studies from our clinic	Ver	139089
14:30	Prof Uwe PAASCH	I'LL GLOBAL - Strategies to enhance ECMV booster delivery by nanoporation		139004
14:45		Others		145547
14:45	Margaret MOLTENI	DIBI MILANO - Electroporation’s new era in skin treatment with mesotherapy		139026
15:00	Margaret MOLTENI	DIBI MILANO - The future of aesthetic treatments: Non-invasive microneedling and multipolar RF		139014
15:15	Monika HEILIGMANN	MONIKA HEILIGMANN - Revolutionizing Lip Care: The Next Era of Non-Invasive Treatments		139092
15:30	Dr Karina RAVERA	CLARIUS - Revolutionizing facial mapping through AI-powered ultrasound		139021
15:45	Luca GUALDRINI	I-TECH INDUSTRIES - Pre and post-surgery with microstimulation technology: from tissue preparation to tissue recovery		139030
16:00	Dr Evgeniya Jane RANNEVA	SKIN TECH PHARMA - Employing new injectable technique for mid face	Ver	139015
16:15	Vicky HERRERO	MILESMAN - Treatment of inflammatory acne with a high-power diode Laser		139022
16:30	Dr Foteini BAGEORGOU	RENAISSANCE - Comprehensive regenerative innovations: Synergistic solutions with PDRN, exosomes, and advanced actives for face, body and beyond		145450
16:45	Dr Fabrizio VIGNOLI	HEXAGON - Aura reality: Shaping the future of aesthetic imaging		139016
17:45	Dr Amit LUTHRA	QR678 - From lab to scalp: The cutting-edge impact of first-in-class QR678 therapy in alopecia		139028

IMCAS World Congress 2025
Programa

Open Stage - Industry sponsored lectures

Las presentaciones

IMCAS World Congress 2025 Programa

Open Stage - Industry sponsored lectures

Las presentaciones

IMCAS World Congress 2025
Programa